Cargando…
Low Dose Naltrexone and Lung Cancer: A Case Report and Discussion
Low dose naltrexone (LDN) has been promising as a complementary medication for patients with a broad range of medical disorders. Although not a proven cure, evidence from clinical trials supports LDN as being a valuable adjunct for disorders in which the immune system plays a centralized role. Addit...
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Cureus
2018
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6126779/ https://www.ncbi.nlm.nih.gov/pubmed/30197847 http://dx.doi.org/10.7759/cureus.2924 |